Autopsy report · NCT00568451

Paclitaxel and Carboplatin or Temozolomide in Treating Patients With Stage IV Melanoma

“Slow accrual.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 6 months after it had already started.
• Ran for about 5 years 10 months before it stopped.
• 12 participants enrolled.
• Results were posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Mayo Clinic

Sponsor type

University, hospital or other

Conditions

Melanoma (Skin)

Interventions

carboplatin; paclitaxel; temozolomide

Participants

12

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.